West Analytical Services, part of West Pharmaceutical Services, is investing in new analytical capabilities to enable customers to pair new and more complex drug products with the right containment systems, delivery systems, and combination products.

Expansion of the capabilities is focused in four areas: (1) extractables and leachables (E&L); (2) container-closure integrity (CCI); (3) particle analysis; and (4) testing for packaging, devices, and combination products.

In E&L, a new ion mobility quadrupole time of flight mass spectrometer has been installed to enable more precise analyses and identification of unknowns. To address demand for CCI analysis, a new frequency modulated spectroscopy (oxygen) analyzer has been acquired to allow for non-destructive analysis versus both time and temperature. For particle testing, West says testing is now supported to give customers an understanding of particle levels in finished products. For testing, the capability to conform to International Organization for Standardization (ISO) methods has been established. 

Source: West Analytical Services